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Abstract
Objective: To determine the global availability of a multicomponent tool predicting
overweight/obesity in infancy, childhood, adolescence or adulthood; and to
compare their predictive validity and clinical relevance.
Design/Setting: The PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-Analyses) guidelines were followed. The databases PubMed, EMBASE,
CINAHL, Web of Science and PsycINFO were searched. Additional articles were
identiﬁed via reference lists of included articles. Risk of bias was assessed using
the Academy of Nutrition and Dietetics’ Quality Criteria Checklist. The National
Health and Medical Research Council’s Levels of Evidence hierarchy was used to
assess quality of evidence. Predictive performance was evaluated using the ABCD
framework.
Subjects: Eligible studies: tool could be administered at any life stage; quantiﬁed
the risk of overweight/obesity onset; used more than one predictor variable; and
reported appropriate prediction statistical outcomes.
Results: Of the initial 4490 articles identiﬁed, twelve articles (describing twelve tools)
were included. Most tools aimed to predict overweight and/or obesity within
childhood (age 2–12 years). Predictive accuracy of tools was consistently adequate;
however, the predictive validity of most tools was questioned secondary to poor
methodology and statistical reporting. Globally, ﬁve tools were developed for
dissemination into clinical practice, but no tools were tested within a clinical setting.
Conclusions: To our knowledge, a clinically relevant and highly predictive
overweight/obesity prediction tool is yet to be developed. Clinicians can,
however, act now to identify the strongest predictors of future overweight/
obesity. Further research is necessary to optimise the predictive strength and
clinical applicability of such a tool.
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Despite numerous past and ongoing public health preven-
tion and intervention initiatives, childhood and adulthood
overweight and obesity (overweight/obesity) remains one
of the most signiﬁcant global public health challenges(1).
The estimated annual global direct economic impact and
worldwide investment to mitigate obesity is currently third
only to smoking and armed conﬂict(2). Within Australia,
childhood overweight/obesity occurs in approximately one
in four (27·6%) children aged 5–17 years, while overweight/
obesity is present in 63·4% of adults(3).
Early identiﬁcation of overweight/obesity within
infants and children is largely contingent on the
screening behaviours of primary care clinicians (PCC)(4).
Currently in the USA and Australia, BMI percentile
screening for overweight/obesity in children is recom-
mended within primary care (age ≥6 years and age
2–18 years, respectively), its role being the detection of
current overweight/obesity(5,6). Yet, once overweight/
obesity has developed in children and adolescents, the
long-term success of intervention strategies is modest(7).
Even with global recognition and recommendation
for the use of BMI percentile screening within paediatric
primary care, it is performed infrequently and
inconsistently(4,8).
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To maximise success in preventive health with currently
available tools, the use of BMI as a predictor of future
overweight/obesity has been considered(9). However,
BMI has limited clinical efﬁcacy in predicting future
overweight/obesity; a large proportion of obese adults do
not identify as obese in childhood(9). Therefore, the utility
of BMI alone as an adequate tool to assess the risk of
future overweight/obesity and potential co-morbidities is
questionable.
Investigation into other anthropometric predictors of
childhood and adulthood obesity has resulted in strong
evidence for maternal pre-pregnancy weight status(10,11),
low(12) and high birth weight(13,14) and rapid infant weight
gain(15) inﬂuencing obesity outcomes in childhood and
adolescence. Additionally, non-anthropometric predictors
have been identiﬁed, such as maternal smoking during
pregnancy(16), breast-feeding duration(17,18) and parental
education(19,20). To maximise the accuracy of overweight/
obesity prediction, a combination of child anthropometric,
maternal, environmental and socio-economic predictors is
likely necessary.
Paediatric PCC are well-positioned to effect change for
children and their families; they have the ability to inﬂu-
ence weight-related behaviours themselves, or initiate
referrals to appropriate health professionals or health
services for further intervention if necessary(4). The ability
of PCC to discriminate low-risk and high-risk infants for
future overweight/obesity may increase the preventive
reach of the health-care system, as early interventions for
high-risk infants can be prioritised before overweight/
obesity develops.
The aim of the present review, therefore, was to assess
the global availability of a prediction tool estimating the
risk of developing overweight/obesity at any stage
throughout infancy, childhood, adolescence or adulthood,
and to compare their predictive validity and relevance to
current clinical settings.
For the purposes of the review, all included ques-
tionnaires, equations, models, indices, evaluations or tools
are collectively referred to as ‘tools’.
Methodology
The protocol for the present systematic review was published
in PROSPERO prior to commencement (CRD42017071048;
available at https://www.crd.york.ac.uk/PROSPERO/display_
record.asp?ID=CRD42017071048).
Search strategy and identiﬁcation of included
articles
The databases PubMed, EMBASE, CINAHL, Web of Sci-
ence and PsycINFO were searched for articles published
since individual database inception until September 2017.
Key words were identiﬁed via literature scoping, group
discussion and consultation with a research librarian.
Identiﬁed key words were translated into a PICO (Popula-
tion, Intervention, Comparison and Outcome)(21) format
and used as the template in searching for all relevant pub-
lications within each database (see online supplementary
material, Table S1). The ﬁnal strategy involved a combina-
tion of key words and controlled vocabulary, limited by
abstract/title to achieve precise results. Two reviewers
(O.J.C. and J.L.W.) independently screened all articles based
on title and abstract. Full-text articles were then screened by
two reviewers (O.J.C. and J.L.W.) based on the speciﬁed
inclusion and exclusion criteria, with any discrepancies
discussed and resolved by a third reviewer (R.L.). The
reference lists of all included articles were also checked to
identify additional articles of relevance. The PRISMA (Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analyses)(22) guidelines were followed in preparing the
review (see online supplementary material, Table S2 for the
PRISMA checklist and Fig. 1 for the PRISMA ﬂow diagram).
Inclusion and exclusion criteria
Articles were included if they described the development
of a prediction tool designed to predict overweight/obe-
sity. Articles were required to meet the following inclusion
criteria:
1. Tool was designed to be administered at any stage
throughout gestation, infancy, childhood, adolescence
and adulthood; and
2. Tool determined the risk of overweight/obesity onset
at any stage throughout infancy, childhood, adoles-
cence or adulthood, irrespective of study design; and
3. Tool employed a multicomponent approach, either
through:
a. The use of more than one predictive variable in the
ﬁnal tool; or
b. If using only one predictive variable, the use of
more than one time-point measurement of the same
variable; and
4. Article described the risk output, which was accepted
to be either of the following:
a. A percentage likelihood of overweight/obesity
development; or
b. A numerical or qualitative score output speciﬁc to
the tool; and
5. Article reported statistical analyses pertinent to predic-
tion tool performance: calibration, discrimination and
decision-curve analysis, i.e. calibration-in-the-large,
calibration slope, goodness-of-ﬁt (P value), receiver
operating characteristic (ROC) curve analysis (area
under the ROC curve (AUC)), sensitivity, speciﬁcity and
the tool’s decision threshold. Positive predictive value
(PPV) and negative predictive value (NPV) were also
considered acceptable, as were odds ratio and/or
relative risk analyses.
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Exclusion criteria were any articles not published in
English, those not published as full-text articles and any
cohorts investigating the outcome within unwell children.
Data extraction and synthesis
The following characteristics of each article were extracted
for qualitative synthesis: year of publication, country,
study type, cohort description, outcome measure,
outcome age and diagnostic criteria. The predictive vari-
ables of each tool were also extracted and, for ease of
reporting, were classiﬁed into one of the groups:
anthropometric; socio-economic/sociodemographic; and
clinical. Clinical predictive variables were classiﬁed
as those representing a clinical factor unrelated to
anthropometric or socio-economic/sociodemographic
elements. The following results of each article were
extracted for quantitative synthesis: calibration outcome
(e.g. calibration-in-the-large; calibration slope; and/or
goodness-of-ﬁt (P value)), AUC (%), sensitivity (%), spe-
ciﬁcity (%), PPV (%), NPV (%) and the decision threshold
of the tool.
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Records identified through database searching
(n 4490)
Records after duplicates removed
(n 2400)
Records screened
(n 2400)
Full-text articles assessed
for eligibility
(n 40)
Articles included in
qualitative synthesis
(n 12)
Articles included in final
analysis
(n 12)
Records excluded
(n 2365)
Full-text articles excluded, with
reasons (n 28):
Investigated risk factor
associations only (n 15)
Abstract only (n 5)
Risk evaluation too broad,
e.g. ‘nutritional risk’ (n 2)
Further validation of
included tools (n 2)
Assessed risk of disease
other than obesity (n 1)
Investigated preventive
effects of environment on
obesity (n 1)
Inadequate methods
explanation (n 1)
Editorial only (n 1)
Additional records identified
through other sources
(n 5)
Fig. 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of search strategy results for
the present systematic review of tools to predict infant, childhood and adulthood obesity
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Prediction tool performance
The optimal predictive accuracy of a tool depends on the
individual outcome being predicted, the costs of mis-
classiﬁcation and the clinical pathway each individual will
enter after risk assessment(23). Therefore, there is no
known standard deﬁnition for statistical predictive out-
comes that justify a tool’s use in a clinical setting. Instead,
prediction tool validity, and thus performance, may be
estimated according to the Alpha, Beta, c-statistic and
Decision-curve analysis (ABCD) framework, developed by
Steyerberg and Vergouwe(24), which considers the fol-
lowing indicators to assess overall prediction tool perfor-
mance: calibration (calibration-in-the-large; calibration
slope); discrimination (AUC); and decision-curve analysis
(sensitivity; speciﬁcity). Indicators pertinent to the ABCD
framework were extracted for each study and compared
qualitatively. For the purposes of the present review,
strength of discriminative accuracy was determined as:
inadequate if AUC< 70%; adequate if AUC= 70–80%; and
excellent if AUC> 80%, as indicated by Lee et al.(25).
Clinical relevance
The clinical relevance or usefulness of a prediction tool
can be deﬁned as its ability to generate a decision
threshold, or a ‘cut-off’ point, to classify patients as low-
risk or high-risk, to contribute to and enhance clinician
decision making(24); however, the strength of a prediction
tool cannot be determined solely by statistical metrics(26) –
practical factors also inﬂuence a tool’s immediate clinical
relevance. To our knowledge, there are no available cri-
teria to objectively assess a prediction tool’s immediate
clinical applicability. Therefore, the authors deﬁned factors
relating to clinical relevance as the following:
1. Author mention, within the article, of tool translatability
to current practice.
2. Ease of clinician accessing predictor variable
information.
3. Deﬁned action and/or referral pathway for individuals
identiﬁed as ‘high-risk’.
Quality assessment and levels of evidence
Full-text articles included in the review were assessed for
quality using the Academy of Nutrition and Dietetics’
Quality Criteria Checklist for Primary Research, located
within the Evidence Analysis Manual (see online supple-
mentary material, Fig. S1)(27). Articles were designated a
positive (+ ), neutral (Ø) or negative (–) quality rating,
according to questions relating to each individual article’s
relevance, validity and risk of bias (see Table 1).
Each included article was then assessed against the
National Health and Medical Research Council’s Levels of
Evidence hierarchy(28) (see online supplementary mate-
rial, Fig. S2). The hierarchy classiﬁes evidence into des-
cending levels of strength (Level I, II, III-1, III-2, III-3, IV)
based on robustness of the study design for a speciﬁc
research question (see Table 1). This informs a study’s
overall level of evidence quality.
Two reviewers (O.J.C. and J.L.W.) independently com-
pleted the quality checklist and Levels of Evidence hier-
archy for each article and any inconsistencies were
discussed with a third reviewer (R.L.) until an agreement
was made.
Results
A total of 4490 articles were identiﬁed from the initial
search. Following removal of duplicates, title and abstract
screening was performed on 2400 articles, with forty
subsequently full-text screened for eligibility. Of these,
twelve articles describing the development of twelve tools
were selected for inclusion in the review (see Fig. 1).
Quality rating and level of evidence
Table 1 presents a summary of all quality and level of
evidence outcomes for each article. No articles were
excluded due to poor quality. Eleven of the twelve
included articles received a neutral rating (Ø), with only
one article receiving a positive quality rating ( + )(29). Ten
included articles were classiﬁed as Level II evidence(29–38).
One article was classiﬁed as Level III-1 evidence(39), while
the study by Druet et al.(40) was classiﬁed as Level III-2
evidence.
Description of study cohorts
Table 2 presents the characteristics of included studies.
The majority of articles utilised established prospective
birth cohort samples (n 9)(29,31,33–38,40) to gather baseline
and outcome data, then employed a retrospective
approach to develop their tool. The size of cohorts used
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Table 1 Quality rating and level of evidence results for studies
included in the present systematic review of tools to predict infant,
childhood and adulthood obesity
Study Quality rating* Level of evidence†
Classen and Hokayem (2005)(30) Ø Level II
de Kroon et al. (2011)(31) Ø Level II
Druet et al. (2012)(40) Ø Level III-2
Manios et al. (2013)(32) Ø Level II
Morandi et al. (2012)(33) Ø Level II
Pei et al. (2013)(34) Ø Level II
Potter and Ulijaszek (2013)(35) Ø Level II
Santorelli et al. (2013)(36) Ø Level II
Seyednasrollah et al. (2017)(39) Ø Level III-1
Steur et al. (2011)(37) Ø Level II
Timpka et al. (2007)(29) + Level II
Weng et al. (2013)(38) Ø Level II
*Academy of Nutrition and Dietetics’ Quality Criteria Checklist for Primary
Research(27): positive ( + ); neutral (Ø); negative (–).
†National Health and Medical Research Council’s Levels of Evidence
hierarchy(28): Level I; II; III-1; III-2; III-3; IV.
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varied considerably, but was typically large: >10 000 par-
ticipants (n 3)(35,38,40); 5000–10 000 (n 1)(29); 2000–5000
(n 4)(30,32–34); 1000–2000 (n 3)(36,37,39); and < 1000
(n 1)(31). As a supplementary component to their meta-
analysis, Druet et al.(40) employed a multivariate logistic
regression approach within a sub-sample of cohorts
(ALSPAC, SEYCHELLES and CPP; see Table 2) to develop
their prediction tool.
Nine of the twelve included articles performed valida-
tion of their tool using internal or external methods, or
both (see Table 2). Of these, ﬁve articles randomised a
varying percentage of participants from their development
cohort into a validation cohort(29,34,38–40). Two articles
performed validation externally using a different
cohort(33,36). Internal validation using bootstrapping
methods was completed for three articles(31,36,37). One
article performed both internal validation using boot-
strapping methods (1000 repetitions) and validation with
an external cohort(36). Three articles(30,32,35) did not per-
form internal or external validation.
Prediction tool design
All tools were designed to be administered post-gestation.
Risk estimation within two tools could be performed solely
by the administering PCC(29,31), with the remaining ten
tools requiring variable input from both the administering
PCC and mother(30,32–40).
Outcome age
Outcome age is the age at which the tool predicts the
likelihood of overweight/obesity onset (see Table 2). No
tools were designed to predict overweight/obesity devel-
opment in infancy and young childhood (≤2 years). The
outcome age of one tool(36) was designated at 2 years;
however, the outcome was only ‘risk for childhood obe-
sity’ at a later, unspeciﬁed age. Nine of the included tools
estimated the risk of overweight/obesity in childhood (age
2–12 years) across singular ages or age ranges: 3 years(38);
3–6 years(39); 7 years(33,40); ≤8 years(30); 8 years(37); 9–12
years(39); 9–13 years(32); ≥9 years(30); 10 years(29,34); and 11
years(40). Only two tools estimated risk of overweight/
obesity development in adolescence (age 13–18 years), at
15–18 years(39) and 16 years(33). Similarly, two tools mea-
sured risk of overweight/obesity development in adult-
hood (age ≥18 years), at 23 years(31,35), 33 years(35) and 42
years(35).
Outcome measure
Obesity was assessed as the single outcome in four
tools(29,32,39,40) (see Table 2). The combined outcome of
overweight and obesity was assessed in seven
tools(30,31,33–35,37,38). One tool investigated the outcome ‘risk
for childhood obesity’(36), deﬁned as BMI > 91st percentile
at 2 years of age in conjunction with a >1 centile band
weight Z-score gain between birth and 2 years of age.
Risk output
Three articles adapted the output of their screening tools
to present an estimated percentage likelihood risk of
future obesity(31–33). A score output unique to the speciﬁc
tool was developed within four articles, presented as
either numerical or qualitative: Manios et al.(32) (numerical
score unique to tool translated into percentage risk of
future obesity); Weng et al.(38) (numerical); Santorelli
et al.(36) (qualitative – high, medium, low); and Potter and
Ulijaszek(35) (qualitative – low-risk, ﬁxed-risk, acute-risk,
high-risk). Within six included tools(29,30,34,37,39,40), risk
estimation was performed via a statistical equation without
a score output.
Predictive variables
The mean number of predictive variables in all
included tools was 4·92 (SD 3·06; range 1–13). Substantial
variability existed between tool variables that largely
depended on the type of baseline and outcome data
available within each cohort. For a description of
predictive variables included within each tool, refer to
Table 3.
Anthropometric
All tools included at least one anthropometric variable,
either from the child only (n 3)(29,31,34) or both the child
and parent (n 9)(30,32,33,35–40). The most common included
variable was a maternal measure of weight (n 9), either
pre-pregnancy (n 2)(32,38) or current (n 7)(30,33,35–37,39,40).
The most common child anthropometric variable included
was birth weight (n 8), classiﬁed as kilograms(30,33–35,37),
SD-score(40), quintiles(38) or Z-scores(36).
Socio-economic/sociodemographic
Seven tools included at least one variable of a socio-
economic nature(30,32–34,37–39), while a sociodemographic
variable was included within ﬁve tools(30,32,36,37,40). Edu-
cation level of either the mother(30,32) or both parents(34)
was the most common socio-economic variable, as was a
measure of income, either per household member(30) or as
a family(34,39). In terms of demographics, ﬁve articles
included sex as a tool variable, all associating female
gender with a greater risk of overweight/obesity
development(30,32,36,37,40).
Clinical
Smoking status was the most commonly included clinical
predictive variable (n 5), deﬁned as maternal smoking
during pregnancy (n 4)(32–34,38), maternal smoking
(n 1)(33) or smoking in the parental house (n 1)(37). Breast-
feeding history was included as a variable within two
tools, categorised as either ‘ever breast-fed in ﬁrst year’
(n 1)(38) or ‘breast-fed partially or wholly’ (n 1)(35).
Two tools(33,39) attempted to enhance the predictive
accuracy of anthropometric and socio-economic variables
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by including genetic variables associated with obesity.
Seyednasrollah et al.(39) derived genetic variables from a
genome-wide association study, using signiﬁcant SNP
(n 19) to create a weighted genetic risk score (WGRS19)
that was included within the ﬁnal predictive tool. Morandi
et al.(33) selected thirty-nine SNP related to obesity,
creating a cumulative genotype score by summing the
number of risk alleles.
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Table 2 Characteristics of studies included in the present systematic review of tools to predict infant, childhood and adulthood obesity
Study Country Study type
Cohort description (study title and participants*)
Outcome
measure
Outcome
age (years)
Diagnostic
criteriaDevelopment Validation
Classen and
Hokayem
(2005)(30)
USA Prospective
cohort
NLSY79
n 4980
– Overweight and
obesity
≤8 and ≥9 CDC
de Kroon et al.
(2011)(31)
Netherlands Prospective
birth cohort
Terneuzen Birth
Cohort
n 762
Bootstrapping
(internal)
1000 repetitions
Overweight and
obesity
23 BMI
(Dutch)
Druet et al.
(2012)(40)
UK Meta-analysis ALSPAC (n 1976)
MRC HCS (n 2981)
MRC NSHD (n 3341)
HAGUENAU
(n 11 812)
SWEDES (n 248)
EUROAM (n 653)
CPP (n 19 355)
PBPP (n 300)
SEYCHELLES
(n 5406)
Total: n 47 661
ALSPAC (n 1976)
CPP (n 19355)
SEYCHELLES
(n 5406)
Sample 1: n 8236
Sample 2: n 8236
Obesity 7 and 11 IOTF
Manios et al.
(2013)(32)
Greece Cross-
sectional
Healthy Growth Study
n 2294
– Obesity 9–13 IOTF
Morandi et al.
(2012)(33)
France Prospective
birth cohort
NFBC1986
n 4032
1. Veneto
Retrospective cohort
n 1503
2. Project Viva
Prospective cohort
n 1032
Overweight and
obesity
7–16 IOTF
Pei et al. (2013)(34) Germany Prospective
birth cohort
GINIplus and LISAplus
Total: n 2272
Training data set:
n 1515
GINIplus and LISAplus
Validation data set:
n 757
Overweight and
obesity
10 WHO
Potter and Ulijaszek
(2013)(35)
UK Prospective
birth cohort
NCDS
n 11752
– Overweight and
obesity
23, 33 and
42
WHO
Santorelli et al.
(2013)(36)
UK Prospective
birth cohort
Born in Bradford (BiB)
n 1868
Bootstrapping
(internal)
1000 repetitions
ALSPAC
Prospective birth
cohort
n 880 (Equation 2)
n 867 (Equation 3)
Risk for
childhood
obesity
2 UK90
Seyednasrollah
et al. (2017)(39)
Finland Prospective
cohort
Cardiovascular Risk in
Young Finns
n 1625
Cardiovascular Risk in
Young Finns
n 637
Obesity 3–6, 9–12
and 15–18
–
Steur et al.
(2011)(37)
Netherlands Prospective
birth cohort
PIAMA
n 1687
Bootstrapping
(internal)
200 repetitions
Overweight and
obesity
8 IOTF
Timpka et al.
(2007)(29)
Sweden Prospective
birth cohort
Children are important,
Swedish only
Total: n 5105
Derivation cohort:
n 2234
Children are important,
Swedish only
Validation cohort:
n 2235
Obesity 10 IOTF
Weng et al.
(2013)(38)
UK Prospective
birth cohort
Millennium Cohort
Study
n 13513
Millennium Cohort
Study
n 1715
Overweight and
obesity
3 IOTF
NLSY79, National Longitudinal Survey of Youth; ALSPAC, Avon Longitudinal Study of Parents and Children; MRC HCS, Medical Research Council Hert-
fordshire Cohort Study; MRC NSHD, Medical Research Council National Survey of Health and Development; HAGUENAU, Haguenau Case–Control Study;
SWEDES, Stockholm Weight Development Study; EUROAM, Formula-fed European Americans Cohort Study; CPP, Collaborative Perinatal Project; PBPP,
Philadelphia Blood Pressure Project; SEYCHELLES, Seychelles Cohort; NFBC1986, Northern Finland Birth Cohort; GINIplus, German INfant Nutritional
Intervention plus environmental and genetic influences on allergy development; LISAplus, Influences of LIfestyle-Related Factors on the Immune System and
the Development of Allergies in Childhood plus Air Pollution and Genetics; NCDS, National Child Development Study; PIAMA, Prevention and Incidence of
Asthma and Mite Allergy; CDC, Centers for Disease Control and Prevention; IOTF, International Obesity Task Force.
*Total number (n) of participants in each study indicates those who participated in the final development of the tool, rather than the initial cohort size.
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Prediction tool performance
Table 4 details the predictive statistical outcomes of each
included tool. Only two studies(33,37) provided all three
metrics (calibration, discrimination and decision-curve ana-
lysis) pertinent to assessing predictive performance, as
described by the ABCD framework(24). Discrimination was
more frequently reported, with nine out of twelve studies
measuring AUC(30–33,36–40). For decision-curve analysis, ten
out of twelve studies reported sensitivity and speciﬁcity
values(29–34,36–38,40). Eight of twelve studies included PPV
and/or NPV statistical outcomes(29,31,33,34,36–38,40). Potter and
Ulijaszek(35) did not perform any statistical analyses related
to predictive accuracy, instead calculating odds ratios and
relative risks for the development of adulthood overweight/
obesity within each risk group (low-risk; ﬁxed-risk; acute-
risk; high-risk). Due to the quantity of calculations and their
heterogeneity to the other included articles, the results are
not presented here.
Calibration
The two studies(33,37) that reported calibration outcomes
used the Hosmer–Lemeshow test for goodness-of-ﬁt.
Similar values were reported for Morandi et al.(33) and
Steur et al.(37), at P= 0·33 and P= 0·3, respectively. This
indicates that their models’ predictions of weight outcome
were consistently correct(41). No studies reported the
calibration outcomes of calibration-in-the-large or cali-
bration slope as per the ABCD framework(24).
Discrimination
Only three tools achieved an excellent(25) AUC outcome
or higher: Santorelli et al.(36), at 85·8% (Equation 1),
86·1% (Equation 2) and 91·1% (Equation 3); Morandi
et al.(33) (obesity prediction tool only), at 85%; and de
Kroon et al.(31) (boys aged 2–6 years only, predicting to
age 23 years), at 83%. As an example, in practice this
means the tool of Morandi et al.(33) can accurately predict
childhood obesity, at age 7–16 years, 85% of the time.
The highest discriminative accuracy outcome achieved for
ﬁve of nine tools reporting AUC was adequate(30,37–40),
with only Manios et al.(32) demonstrating inadequate
discriminative accuracy (63·8%) for their tool predicting
obesity at age 9–13 years.
In tools that assessed discriminative accuracy outcomes
for both obesity and overweight and obesity, the outcome of
obesity was associated with stronger predictive
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Table 3 Description of predictive variables within each tool included in the present systematic review of tools to predict infant, childhood and
adulthood obesity
Study
Total no.
of
variables
Predictive variables
Anthropometric Socio-economic/sociodemographic Clinical
Classen and
Hokayem
(2005)(30)
13 Maternal BMI; birth weight (kg) Full-time v. at-home mothers; mother’s marital
status; number of household members; income
per household member; health insurance
status; maternal educational level; ethnicity;
gender
Order of birth among siblings;
mother’s age at time of birth;
indications of child and youth
depression
de Kroon et al.
(2011)(31)
1 BMI SD-score at ages 2, 4 and 6
years
– –
Druet et al.
(2012)(40)
4 Weight SD-score gain (0–1
year); birth weight SD-score;
maternal BMI
Gender –
Manios et al.
(2013)(32)
4 Maternal pre-pregnancy BMI;
weight change (0–6 months)
Gender; maternal educational level Maternal smoking during
pregnancy
Morandi et al.
(2012)(33)
6 Parental BMI; birth weight (kg);
maternal GWG
Number of household members; maternal
occupation
Smoking habits (maternal smoking
or gestational smoking)
Pei et al.
(2013)(34)
5 Birth weight (kg); BMI (age 60–
64 months)
Parental educational level; family income Maternal smoking during
pregnancy
Potter and
Ulijaszek
(2013)(35)
4 Birth weight (kg); parental BMI
(at 11 years old)
– Breast-feeding partially or wholly;
physical activity (at 11 years old)
Santorelli et al.
(2013)(36)
5 Birth weight Z-score; weight Z-
score change (birth to
screening age); maternal
BMI
Female sex Age (determines which equation is
used)
Seyednasrollah
et al.
(2017)(39)
4 BMI SD-score; maternal BMI Family income WGRS97 or WGRS19 (genetic
model only)
Steur et al.
(2011)(37)
6 Paternal BMI; maternal BMI;
birth weight (kg)
Female sex Smoking in parental house;
hospital delivery
Timpka et al.
(2007)(29)
1 Boys: obesity at 4- and 5-years
check-ups; girls: BMI above
20 kg/m2 at 5-year check-up
– –
Weng et al.
(2013)(38)
6 Birth weight (quintile); weight
change (0–1 year); maternal
pre-pregnancy BMI; paternal
BMI
– Maternal smoking during
pregnancy; ever breast-fed
infant in first year
SD-score, standard deviation score; GWG, gestational weight gain; WGRS, weighted genetic risk score.
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performance. Morandi et al.(33) achieved an excellent AUC
value (85%) for their obesity prediction tool, but an ade-
quate AUC value for their overweight and obesity tool
(75%). Classen and Hokayem(30) demonstrated adequate
discriminative accuracy for their obesity prediction tool, but
inadequate discriminative accuracy for their overweight tool.
The excellent AUC value of de Kroon et al.’s(31) model
(83%) (boys aged 2–6 years, predicting to age 23 years)
could not be replicated among their other prediction mod-
els, with all others achieving adequate AUC values.
Decision-curve analysis
Morandi et al.(33), Santorelli et al.(36) and Weng et al.(38)
reported the highest sensitivity values of all tools at 79%
(obesity tool), 77% (Equation 3) and 76·9%, respectively.
Again, using Morandi et al.(33) as an example, their tool
would predict childhood obesity, at age 7–16 years,
correctly in 79% of children initially assessed at baseline.
The corresponding speciﬁcity for each of these tools was
similarly strong for Morandi et al.(33) (75·5%) and Santor-
elli et al.(36) (85·2%), while not as strong for Weng et al.(38)
(66·5%). In the tool of Morandi et al.(33), 75·5% of children
assessed at baseline would be correctly predicted to not
develop childhood obesity. Of the ten studies reporting
decision-curve analysis, two did not report a correspond-
ing decision threshold related to the tool’s sensitivity and
speciﬁcity values(29,34), meaning it was unclear how the
sensitivity and speciﬁcity values would be prioritised to
inform clinical decisions.
Clinical relevance
The immediate translatability of the developed prediction
tool to clinical practice was mentioned within ﬁve
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Table 4 Predictive statistical outcomes, according to the ABCD framework*, of each tool included in the present systematic review of tools to
predict infant, childhood and adulthood obesity
Calibration Discrimination Decision-curve analysis
Study
Goodness-of-fit
(P value) AUC (%)† Sensitivity (%) Specificity (%)
Decision
threshold‡ PPV (%) NPV (%)
Classen and
Hokayem (2005)(30)
– Obesity; overweight:
70; 65·7 (basic child)
73; 68·4 (full child)
72·9; 68·5 (full youth)
58·9 (basic
child)
60·6 (full child)
62·9 (full youth
31·4 (basic
child)
31·7 (full child)
34·4 (full youth)
15·70% – –
de Kroon et al.
(2011)(31)§
– Boys¶:
79 (2–4 years)
83 (2–6 years)
Girls¶:
76 (2–4 years)
79 (2–6 years)
28 (2–4 years)
38 (4–6 years)
36 (2–6 years)
92 (2–4 years)
93 (4–6 years)
93 (2–6 years)
50% 58 (2–4 years)
66 (4–6 years)
67 (2–6 years)
–
Druet et al. (2012)(40)§ – 77 70·1 71·2 ≥30% 6·9 98·7
Manios et al.
(2013)(32)
– 63·8 (95% CI 60·2,
67·5)
54 65 ≥5 – –
Morandi et al.
(2012)(33)§
0·33 Obesity: 85
Overweight/obesity:
75
Obesity: 79
Overweight/
obesity: 63
Obesity: 75·5
Overweight/
obesity: 78
75th
percentile
Obesity: 4
Overweight/
obesity: 21
Obesity: 99·5
Overweight/
obesity: 96
Pei et al. (2013)(34)§ – – 37·1 95·1 – 72·5 86·1
Potter and Ulijaszek
(2013)(35)
– – – – – – –
Santorelli et al.
(2013)(36)§,║
– 85·8 (Equation 1)
86·1 (Equation 2)
91·1 (Equation 3)
71·1
(Equation 1)
69·4
(Equation 2)
77·0
(Equation 3)
84·5
(Equation 1)
84·2
(Equation 2)
85·2
(Equation 3)
≥20% 28·8
(Equation 1)
27·5
(Equation 2)
32·2
(Equation 3)
97·1
(Equation 1)
97·0
(Equation 2)
97·6
(Equation 3)
Seyednasrollah et al.
(2017)(39)§
– WGRS19 & clinical
factors: 76·9
WGRS94 & clinical
factors: 74·9
Clinical factors: 74·7
– – – – –
Steur et al. (2011)(37)§ 0·3 75·4 67·2 74·9 ≥15% 30·2 93·4
Timpka et al.
(2007)(29)§
– – 21 (boys)
41 (girls)
100 (boys)
100 (girls)
– 80 (boys)
82 (girls)
–
Weng et al.
(2013)(38)§
– 75·5 76·9 66·5 ≥25 37 89
AUC, area under the receiver operating characteristic curve; PPV, positive predictive value; NPV, negative predictive value; WGRS, weighted genetic risk score.
*If internal or external tool validation was performed, only these quantitative outcomes have been reported, rather than also including the quantitative outcomes
of the tool’s development phase. If validation was not performed, the quantitative values in Table 4 are outcomes of the tool’s development phase only.
†Strength of discriminative accuracy was determined as: inadequate if AUC< 70%; adequate if AUC= 70–80%; and excellent if AUC> 80%.
‡Where predictive statistical analyses had been performed using multiple decision thresholds for each tool, quantitative data were extracted from the median
cut-off point only and rounded up where appropriate. Where the author has not designated a decision threshold, this cell has been left blank.
§Tool validation completed.
║Tool is administered at ages: Equation 1 at 6 (SD 1·5) months; Equation 2 at 9 (SD 1·5) months; Equation 3 at 12 (SD 1·5) months.
¶Tool is administered at the upper age threshold.
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studies(31–33,36,37). Within three of these(31,32,37), a risk
graph or chart was developed for clinical use to provide
an output of estimated risk. Morandi et al.(33) developed a
spreadsheet-based risk calculator with an output of per-
centage estimated risk. Santorelli et al.(36) integrated their
prediction tool within an app, ‘Healthy Infant Weight?’;
however, at the time of review, this app was not available
for download.* Those studies that did not mention tool
translatability to clinical practice developed a statistical
prediction equation only(29,30,34,35,38–40).
Predictor variable data collection was achieved by
combined self-report and medical record access for
ﬁve prediction tools(32–34,38,40). Methods of only self-report
and medical record access were appropriate within
two prediction tools(35,37) and one prediction tool(36),
respectively. Two prediction tools required only anthro-
pometric measurement of the individual(29,31). One pre-
diction tool required the collection of a genetic variable
in the form of obesity-related SNP(39). The tool of Classen
and Hokayem(30) included an indication of child depres-
sion and therefore required a clinical assessment
component.
Only one prediction tool(36) provided a component
beyond risk prediction, with the addition of relevant
educational material and resource links for those identiﬁed
as high-risk. No tool described a relevant referral pathway,
to either a tertiary or primary care health service, or a
community-based preventive or treatment programme, for
individuals identiﬁed as high-risk.
Discussion
The current systematic review provides a comprehensive
summary of known available tools designed to predict
overweight/obesity via an estimation of risk. Twelve tools
were developed within speciﬁc populations, with
nine(29,31,33,34,36–40) of these having been validated either
using internal or external methods, or a combination of
both. The prediction tools developed and validated by
Morandi et al.(33) and Steur et al.(37) were assessed as the
strongest overall, secondary to: strong congruency with
the ABCD framework for assessing prediction tool validity;
adequate–excellent discriminative accuracy; internal(33,37)
and external(33) tool validation; and relevance to current
clinical practice.
Prediction tool performance
Assessing the validity of a prediction tool does not solely
rest with its applicability to multiple settings. Robust
reporting of outcomes pertinent to predictive performance
is crucial in the development of any prediction tool. Fol-
lowing the ABCD framework(24) for assessing prediction
tool validity, only two studies(33,37) were identiﬁed as
having reported all outcomes necessary: calibration; dis-
crimination; and decision-curve analysis. Despite this, the
calibration metric described within these two studies has
been demonstrated as inappropriate: the Hosmer–Leme-
show goodness-of-ﬁt test is not recommended as P value
outputs can vary by sample size and are thus deemed
imprecise(24). Instead, calibration-in-the-large and assess-
ment of the calibration slope is recommended(24). Poor
methodological considerations and inadequate reporting
of all measures necessary to assess prediction tool per-
formance are consistent across multiple diseases and set-
tings, not just overweight/obesity, as identiﬁed in a recent
systematic review(42).
Discriminative accuracy (AUC %) was the most com-
monly reported statistical outcome relevant to predictive
performance. Excellent discriminative accuracy is expected
in tools which predict overweight/obesity as a proximal
outcome. Equation 3, a prediction tool of Santorelli et al.(36)
designed to be administered at 12 (SD 1·5) months to predict
the risk of childhood obesity at 2 years of age, achieved the
highest AUC value at 91·1%. Notably, only the outcome of
‘risk for childhood obesity’ is associated with this prediction
tool, rather than the actual outcome of obesity. No follow-up
anthropometric data were collected at a later time point in
childhood and no age range was speciﬁed for ‘childhood
obesity’. Similarly, in their prediction of persistent childhood
obesity (i.e. obesity at ages 7 and 16 years), Morandi et al.(33)
produced an excellent AUC outcome (85%), which is also
expected considering the high likelihood of childhood
obesity tracking into adolescence(14).
In its mere classiﬁcation of individuals who develop
overweight/obesity compared with those who do not,
discriminative accuracy is not a true indicator of clinical
usefulness. When determining the overall goal of the tool,
consequences secondary to false negative and false posi-
tive predictions also need to be considered(43). Designa-
tion of the decision threshold (cut-off point) is a subjective
decision at the discretion of the end user, informed by the
priority assigned to high or low sensitivity and speciﬁcity
values. Consideration needs to be made for the tool’s
overall impact on health service delivery; the decision
threshold should be assigned based on characteristics of
the health system in which the predictive tool is to be
embedded(24). For example, Timpka et al.(29) prioritised
strong speciﬁcity in order to avoid unnecessary interven-
tions, reducing health system burden and cost. Other end
users may prioritise sensitivity to maximise the number of
children identiﬁed who will go on to develop overweight/
obesity and thus be highly eligible for preventive inter-
vention. This approach, however, may be feasible only for
health systems with access to an evidence-based pre-
ventive intervention.
Considering the low prevalence of weight discussion
and overweight/obesity diagnosis in a paediatric clinical
setting(44), the availability of a structured, user-friendly and
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* At the time of submitting the revised manuscript, the app ‘Healthy Infant
Weight?’ was not available for download.
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outcomes-based platform to a clinician may also simply
encourage the discussion of weight with families and
children. This action in itself improves clinical service
delivery and may lead to appropriate intervention. Prior
to the development of a clinically relevant prediction
tool, clinicians can also begin to identify the strongest
predictors for overweight/obesity as part of routine
clinical practice. Predictors most commonly included in
the tools of the present review, such as maternal over-
weight/obesity, high birth weight, low parental educa-
tion and maternal smoking during pregnancy, can be
assessed by the clinician to inform an overall,
subjective risk assessment to inﬂuence preventive clinical
decisions.
Two articles(33,39) attempted to enhance their prediction
tool with the addition of genetic risk factors derived from a
genome-wide association study. The addition of a cumu-
lative genetic score based on thirty-nine obesity pre-
disposing SNP did not improve discriminative accuracy of
Morandi et al.’s(33) tool compared with using traditional
risk factors alone and was excluded as a variable in the
ﬁnal tool. Conversely, Seyednasrollah et al.(39) reported
that inclusion of a weighted genetic risk score based on
nineteen SNP slightly improved the predictive accuracy
of the tool compared with clinical factors alone (AUC
76·9% v. 74·7%) in both the development and validation
cohorts for children aged 3–6 years. Globally, only limited
added clinical value has been reported for the use
of genetic factors in accurately predicting adulthood
obesity(45). Potential exists for genetic factors to add
strength to prediction tools; however, the clinical utility
of such tools is questionable, considering the timely pro-
cess involved with obtaining, securing and analysing
genetic data.
Clinical relevance
For the successful dissemination of a health service inno-
vation within a clinical setting, a combination of quanti-
tative and qualitative development, implementation and
evaluation processes is necessary(46). Five prediction
tools(31–33,36,37) included within the review had been
modiﬁed with the intention of integration into clinical
practice, via a risk graph/chart, spreadsheet-based calcu-
lator or app. Despite this, there had been no known
attempt by the authors to progress to widespread clinical
uptake within the health-care sector. It remained unclear
how the prediction tools may integrate with population
electronic health systems, PCC practice management
software or the Internet. While these tools could theore-
tically be used within current practice, issues remain,
including: perceived usability; clinician awareness and
uptake; clinician access to required child and maternal
anthropometric data; potential need to upskill existing
PCC and train new PCC; the effect on clinician behaviour
change, including the tool’s inﬂuence on clinical decision
making; as well as actual overweight/obesity outcomes for
all children exposed to the tool.
In developing a clinically valid overweight/obesity
prediction tool, the most appropriate outcome age for
preventive success needs to be determined. Prediction
during adolescence may be a suitable medium between
childhood and adulthood. Within the analysis of their
large-sampled longitudinal cohort (n 17 638), Potter and
Ulijaszek(35) identiﬁed that a large proportion of measured
overweight/obese adults did not present as overweight/
obese in childhood (aged 11 years). This is consistent with
ﬁndings of a recent systematic review and meta-analysis(9),
demonstrating that childhood weight status is a poor
predictor of adulthood weight status: 70% of obese adults
were not obese as children. There is considerable evi-
dence, however, supporting the association between
adolescent overweight/obesity and adulthood over-
weight/obesity(47–50). Additionally, adolescent over-
weight/obesity is strongly and consistently associated with
adulthood morbidity, including CVD(51,52) and type 2
diabetes mellitus(51,53). The outcome of adolescent over-
weight/obesity may be proximal enough to ensure ade-
quate predictive accuracy, yet distal enough to encompass
prediction of adulthood obesity and chronic disease in
certain cases.
Prediction tool development needs to consider the
optimal time point for tool administration. Tools that
require the input of predictor variables in late childhood,
such as those by de Kroon et al.(31) (age 6 years) and
Potter and Ulijaszek(35) (age 11 years), arguably provide
an estimation of risk that is too late to elicit a preventive
beneﬁt. Modiﬁable predictors within infancy, such as
prolonged breast-feeding exclusivity and duration(17,54,55),
as well as appropriate timing of introduction to solids
(approximately 6 months of age)(56,57), have been
demonstrated as protective against future overweight/
obesity. Additionally, the ability of a prediction tool to be
administered at multiple time points is highly desirable,
such as the tool of Santorelli et al.(36). The variability of
health service visits in the early years is high between
individuals. It is unrealistic to expect all infants or young
children to be assessed for overweight/obesity risk at
exactly the same time point(36). A prediction tool validated
only for administration at one time point may miss high-
risk individuals who would have beneﬁted from pre-
ventive intervention.
The concurrent availability of a cost-effective, evidence-
based preventive intervention and/or referral pathway for
individuals identiﬁed as high-risk is critical for a clinically
embedded obesity prediction tool. Santorelli et al.(36)
developed the only prediction tool to incorporate a com-
ponent beyond risk prediction, with the inclusion of
generic, evidence-based recommendations for healthy
eating, physical activity and positive parenting behaviours
within their app. To embed an electronic tool within
clinical practice creates capacity to integrate individualised
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recommendations based on risk output. Potential exists for
further risk-determined customisation, perhaps providing
a referral pathway for the clinician to action, a recom-
mendation to emphasise positive early feeding habits or
the encouragement of frequent anthropometric monitor-
ing by the clinician.
Strengths and limitations of included articles
A number of limitations were seen as trends across all
included articles. All studies were conducted in high-
income countries. Multiple articles were restricted in their
choice of tool variables. Depending on the cohort used to
inform the prediction tool, only certain baseline variables
and outcome measures were accessible, potentially limit-
ing the accuracy and scope of the tool. None of the
included articles measured body composition as indicators
of overweight/obesity outcomes. In addition, there was
considerable heterogeneity in each study’s justiﬁcation for
including its predictive variables, with most only extracting
the strongest variables observed within a single
cohort(29,32,33,36,39) and some providing no justiﬁca-
tion(30,31). A strength of all included articles was the large
sample sizes commonly used within both the develop-
ment and validation phases.
Limitations of review
The principal limitation of the present review was the
inability to perform a quantitative synthesis of the tools’
predictive strength. The heterogeneity observed in each
tool’s outcome measure, diagnostic criteria used, outcome
age and chosen methods of statistical analysis suited a
qualitative approach. While no articles were excluded
secondary to a low quality rating, only one included article
achieved a high quality rating, potentially subjecting the
review to bias. Additionally, the review focused solely on
studies detailing the development and validation of pre-
diction tools and thus excluded any follow-up validation
performed.
Conclusions
The current systematic review is the ﬁrst of its kind
aiming to determine the availability, clinical relevance and
validity of tools to predict overweight/obesity develop-
ment across the life course. Our ﬁndings indicate that
further research should prioritise the following: optimising
the predictive strength of currently available, population-
speciﬁc tools; improving the immediate clinical applic-
ability of existing prediction tools; and the methodologi-
cally robust development of new prediction tools in
novel countries and settings. Following, investigation
into the use of a validated prediction tool concurrently
with an overweight/obesity preventive intervention for
subjects identiﬁed as high-risk could be considered.
Clinicians can act now to identify strong predictors, in
infancy, for future overweight/obesity, such as maternal
overweight/obesity and high birth weight. The successful
integration of an overweight/obesity prediction tool within
clinical practice may be a valid front-line preventive
strategy to assist in decreasing overweight/obesity
prevalence.
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